CD-TREAT Diet: a Novel Therapy for Active Luminal Crohn's Disease

Launched by NHS GREATER GLASGOW AND CLYDE · May 25, 2017

Keywords

ClinConnect Summary

Children and adults who are eligible to participate will be identified by medical staff. A member of the clinical team will briefly inform potential participants about the study via the phone, via e-mail, or at the clinic. After the end of the clinical appointment and if the patient and/or the parent/carer are agreeable, a member of the clinical team will introduce the eligible participants to the researcher who will explain the study in full and answer any questions they might have. During this meeting, the researcher will discuss the specific aspects of dietary treatment with CD-TREAT and...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • previously diagnosed patients with active luminal CD \[paediatric (6-15 years old) wPCDAI≥12.5) or adult (16-65 years old) HBI≥5\]
• • in need of starting induction treatment
• Exclusion Criteria:
• • pregnancy
• • use of antibiotics currently or during the past 1 month
• • major change in inflammatory bowel disease (IBD) induction or maintenance therapy in the preceding 3 months (defined as change in type of treatment)
• • minor change in IBD induction or maintenance therapy in the preceding 1 month (defined as adjustment of treatment dosage)
• • enrolment in other studies investigating the efficacy of other novel therapies in disease activity
• • disease severity sufficient to warrant hospital admission
• • food allergies incompatible with CD-TREAT (e.g. cow's milk allergy)